Efficacy and Safety of Jiedu Tongluo Granules for Post-stroke Depression
Status:
Completed
Trial end date:
2018-01-24
Target enrollment:
Participant gender:
Summary
To explore the efficacy and safety of Jiedu Tongluo granules for post stroke depression. A
randomized, double-blind, placebo-controlled clinical trial was designed. The treatment group
was administered the Jiedu Tongluo granules, while the control group was administered the
placebo.
Phase:
Early Phase 1
Details
Lead Sponsor:
Xiyuan Hospital of China Academy of Chinese Medical Sciences